Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer

Autor: Kakajan Komurov, Brian Gebelein, Larry Sallans, Priyanka Arora, Jianqiang Wu, Matthew T. Weirauch, Frank B. Furnari, Sean E. Lawler, Nishtha Gupta, Angelo D'Alessandro, Gary A. Gudelsky, Biplab Dasgupta, Joseph Salomone, Kwangmin Choi, Nicole Oatman, Nupur Dasgupta, Sreeja Parameswaran, Cameron Brennan, Mruniya V. Gawali, Julie A. Reisz, Pankaj B. Desai
Rok vydání: 2021
Předmět:
Zdroj: Science Advances
ISSN: 2375-2548
DOI: 10.1126/sciadv.abd7459
Popis: Genetic and epigenetic mechanisms determine SCD inhibitor sensitivity and acquired resistance through FOSB in cancer.
The lipogenic enzyme stearoyl CoA desaturase (SCD) plays a key role in tumor lipid metabolism and membrane architecture. SCD is often up-regulated and a therapeutic target in cancer. Here, we report the unexpected finding that median expression of SCD is low in glioblastoma relative to normal brain due to hypermethylation and unintentional monoallelic co-deletion with phosphatase and tensin homolog (PTEN) in a subset of patients. Cell lines from this subset expressed undetectable SCD, yet retained residual SCD enzymatic activity. Unexpectedly, these lines evolved to survive independent of SCD through unknown mechanisms. Cell lines that escaped such genetic and epigenetic alterations expressed higher levels of SCD and were highly dependent on SCD for survival. Last, we identify that SCD-dependent lines acquire resistance through a previously unknown FBJ murine osteosarcoma viral oncogene homolog B (FOSB)–mediated mechanism. Accordingly, FOSB inhibition blunted acquired resistance and extended survival of tumor-bearing mice treated with SCD inhibitor.
Databáze: OpenAIRE